Category Archives: Announcements

Important bulletins about the library, access and service changes, and library resources

Advancing Authorship Webinar: JoVE: Going Beyond Video

Posted on by

Join us and learn more about JoVE’s publication process and why videos stand out as a viable approach to foster reproducibility, support training, and develop playlists that can be used as part of a customized course curriculum.

This session will review the publication and filming process, from start to finish and highlight new enhancements that go beyond just producing a video, such as the JoVE’s Methods Collections and new publication formats.

Special guest speakers include JoVE’s Global Scientific Advisor, JoVE’s Director of Editorial, and two staff members from Memorial Sloan Kettering – Assistant Laboratory Member and Associate Attending who will be sharing their recent experiences with this publisher.

Do not forget to bring your questions as there will be time for attendees to participate in an interactive Q&A discussion.

Date: Wednesday, December 6, 2023
Time: 12:00 PM to 1:00 PM, EST
Zoom Webinar: Register Now

Speakers’ Bios:

Thomas Karam, MSc, Global Scientific Advisor, JoVE obtained his degree in Biochemistry from the University of Portsmouth, producing a dissertation in the uses of stem cells in regenerative medicine. He then went on to obtain a master’s degree in Stem Cells and Regenerative Therapies: From Bench to Market, from King’s College London. His masters focused on creating a novel cell therapy using stem cells, with a focus on ameliorating the pathological effects of late onset Alzheimer’s disease. Tom joined JoVE as a Scientific Advisor and now works with research institutions/companies and universities all around the world.

Manu Jain, MD, Associate Attending, Department of Dermatology, Memorial Sloan Kettering Cancer Center, is a trained pathologist and specializes in the ground-breaking field of non-invasive optical in vivo and ex vivo imaging including multiphoton microscopy (MPM), confocal microscopy, optical coherence tomography (OCT), and full-field optical coherence tomography (FFOCT). Dr. Jain uses these devices to noninvasively guide the diagnosis and management of patients with skin cancers. She has extensively published in this field and has been an invited speaker in multiple National and International meetings. She is the Director of the Annual CME-accredited Confocal Microscopy course at MS, the co-founder and Vice-President of the Noninvasive Skin Imaging group of the Americas (NISIA), and a founding member of the Cutaneous Imaging Expert Resource Group of AAD. Dr. Jain serves as a Program Committee Member in the Dermatology and Plastic Surgery conference of the renowned Annual SPIE Photonics conference and was a past Secretary of the International Society of Teledermatology.

Ron Myers, PhD, Director of Editorial, JoVE  obtained his PhD from Tufts University in cellular, molecular, and developmental biology where he used various biochemical techniques including immunohistochemistry, RT-PCR, western blotting, ELISA, cell proliferation and migration assays, immunocytochemistry, as well as in situ zymography. Using these tools, his work involved assessing the expression of CCN5, a key matricellular protein, in the context of mouse embryonic development, as well as in the investigation of molecular pathways underlying this protein’s function in rat vascular smooth muscle cells. Following the completion of his graduate research in 2010, he continued his work at Tufts as a postdoctoral fellow, where he used various confocal microscopy techniques in order to study both morphology and action of dynamic subcellular structures known as podosomes. In 2011, he pursued a new postdoctoral fellowship at the Brigham and Women’s Hospital, an affiliate of Harvard Medical School, where he studied arrestin proteins and their interactions with various G protein-coupled receptors in the context of fructose metabolism. In 2015, he joined the editorial team at the Journal of Visualized Experiments (JoVE), where he worked as a Scientific Editor until early 2020. The Editor position consisted of acquiring scientific articles (with a special focus on Neuroscience and Cancer Research) highlighting cutting edge research and techniques for the journal. At the beginning of 2020, he moved on to the Director of Editor position at JoVE, leading a team of approximately 20 Editors, and other employees with the common goal of recruiting high-quality content for the journal. He also coordinated interaction between the Editorial department and various other departments at JoVE including the Peer Review department, IT department, and Video Production department.

Fabio Vanoli, PhD, Assistant Laboratory Member, The Cristina Antonescu Lab, Memorial Hospital Research Laboratories, Memorial Sloan Kettering Cancer Center has a longstanding interest in the study of DNA double strand break (DSB) repair mechanisms. As a graduate student, he used the model system Saccharomyces cerevisiae to investigate the role of DNA repair pathways in response to treatment with a class I histone deacetylases inhibitor, valproic acid (VPA). Results from this work showed that HDAC inhibition destabilizes the response to DSB through an autophagic pathway, suggesting a possible use of HDAC inhibitor in combination regimens with cytotoxic chemotherapy. During his postdoctoral training he focused his research on the identification of genotoxic effects, in normal human and murine cell lines, associated with PARP inhibitor treatment. Using different approaches, he discovered that short treatment with PARP inhibitor is sufficient to cause genomic instability as demonstrated by the increase in duplication events and in the formation of translocation. Using the CRISPR-Cas9 technology combined with homology directed repair (HDR), he also developed a method for the efficient recovery of cell lines harboring cancer relevant chromosomal translocation with inducible expression of fusions. These models are currently being used to study the molecular mechanisms leading to tumorigenesis and to identify clinically relevant targets for the treatment of those tumors. Fabio Vanoli is the course director for the Multi-Institutional Responsible Conduct of Research (RCR) program sponsored by MSK, Weill Cornell Medicine, Rockefeller University, and Hospital for Special Surgery. He is an Associate Director in Compliance and Internal Audit. Previously, he was an Assistant Lab Member (Assistant Attending Biologist) at MSK, with a research interest in prostate cancer.

Advancing Authorship Webinar: The Impact of AI on the Scholarly Publishing Landscape

Posted on by

The release of ChatGPT has generated considerable attention to generative AI. Those involved with scholarly publishing must be vigilant in understanding and managing AI technological developments that impact their work.

How will publishers maintain the integrity of the scholarly record? Manage and weed out non-existent articles? Detect research faked by sophisticated AIs? Adopt and implement policies that address AI?

Join us for presentations and conversation on how JAMA (Journal of the American Medical Association) is evaluating generative AI. JAMA’s Editor in Chief and Executive Managing Editor will share their experiences about what they have been seeing in the editorial process and the new policies developed around use of large language models (LLMs) in manuscript development and peer review. In addition, hear a preliminary view of generative AI from a member of the Memorial Sloan Kettering’s Compliance and Internal Audit department.

Bring your questions about this growing issue as there will be time for attendees to participate in an interactive Q&A.

Date: Wednesday, October 4, 2023
Time: 12:00 PM to 1:00 PM, EST
Zoom Webinar: Register Now

Speaker Bios:

Kirsten Bibbins-Domingo, PhD, MD, MAS, is the 17th Editor in Chief of JAMA (Journal of the American Medical Association) and the JAMA Network. She is the Lee Goldman, MD Endowed Professor of Medicine and Professor of Epidemiology and Biostatistics at the University of California, San Francisco.

Dr. Bibbins-Domingo is a general internist, cardiovascular disease epidemiologist, and a national leader in prevention and interventions to address health disparities. She is a physician-scientist who has used observational studies, pragmatic trials, and simulation modeling to examine effective clinical, public health, and policy interventions aimed at prevention.

Dr. Bibbins-Domingo previously served as the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine and the Chair of the Department of Epidemiology and Biostatistics at UCSF. She co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital that generates actionable research to advance health equity and reduce health disparities in the San Francisco Bay Area, California, and nationally.

Dr. Bibbins-Domingo was a member of the US Preventive Services Task Force from 2010-2017 and led the Task Force as the vice-chair and chair from 2014-2017. She is an elected member of the American Society for Clinical Investigation, the Association of American Physicians, the National Academy of Medicine, and the American Academy of Arts and Sciences.

Annette Flanagin, RN, MA, FAAN, is Executive Managing Editor and Vice President of Editorial Operations for JAMA and the JAMA Network.

Before joining JAMA, Ms. Flanagin held editorial positions with other journals published for health care professionals, and before that, she practiced cardiology nursing. She is a graduate of Georgetown University, with a BS in nursing and an MA in English Literature.

Ms, Flanagin is Past President of the Council of Science Editors (CSE) and has been honored with the CSE Award for Meritorious Achievement and the John P. McGovern Award for preeminent contribution to medical communication by the American Medical Writers Association. She serves as the Executive Director of the International Congresses on Peer Review and Scientific Publication and as Co-Director of the African Journal Partnership Program. She is a Fellow in the American Academy of Nursing and a member of the board of STM: International Association of Scientific, Technical and Medical Publishers. Ms. Flanagin has co-developed a number of guidelines and policies to guide authors, editors, and publishers in scientific publication and is a committee member and author of the AMA Manual of Style: A Guide for Authors and Editors. She participates in research, lectures, and publishes on issues related to scientific publication for authors, editors, and publishers.

Philip Watson, PhD, is the course director for the Multi-Institutional Responsible Conduct of Research (RCR) program sponsored by Memorial Sloan Kettering (MSK), Weill Cornell Medicine, Rockefeller University, and Hospital for Special Surgery. He is an Associate Director in Compliance and Internal Audit at MSK. Previously, he was an Assistant Lab Member (Assistant Attending Biologist) at MSK, with a research interest in prostate cancer.